FENC
Fennec Pharmaceuticals Inc
NASDAQ: FENC · HEALTHCARE · BIOTECHNOLOGY
$6.26
-6.57% today
Updated 2026-04-29
Market cap
$235.81M
P/E ratio
—
P/S ratio
5.28x
EPS (TTM)
$-0.34
Dividend yield
—
52W range
$6 – $10
Volume
0.2M
Fennec Pharmaceuticals Inc (FENC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $170000.00 | $170000.00 | $1.47M | $21.25M | $47.54M | $45.42M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +0.0% | +767.2% | +1341.6% | +123.7% | -4.4% |
| Cost of revenue | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | $0.00 | $82592.00 | $1.26M | $3.18M | $3.83M |
| Gross profit | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $170000.00 | $0.00 | $1.39M | $19.99M | $44.35M | $41.59M |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 100.0% | 0.0% | 94.4% | 94.1% | 93.3% | 91.6% |
| R&D | $14.00M | $10.91M | $10.37M | $2.11M | $708000.00 | $1.49M | $2.08M | $597000.00 | $357000.00 | $256000.00 | $472000.00 | $1.94M | $5.01M | $5.61M | $5.11M | $4.94M | $3.39M | $56000.00 | $307000.00 | $254376.00 |
| SG&A | $16.80M | $3.28M | $3.52M | $1.21M | $3.90M | $1.94M | $1.54M | $1.33M | $2.52M | $1.63M | $2.40M | $5.01M | $5.40M | $7.40M | $12.95M | $12.24M | $17.72M | $20.59M | $23.05M | $46.91M |
| Operating income | $-19.06M | $-14.19M | $-13.89M | $-3.22M | $-4.60M | $-3.44M | $-3.62M | $-1.93M | $-2.88M | $-1.89M | $-2.87M | $-6.95M | $-10.41M | $-13.01M | $-17.89M | $-17.07M | $-21.69M | $-12.77M | $2.57M | $-6.86M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -10520.6% | -10042.0% | -1471.6% | -60.1% | 5.4% | -15.1% |
| EBITDA | $-17.91M | $-14.19M | $-13.89M | $-2.60M | $-4.60M | $4.55M | $-5.18M | $1.79M | $-2.88M | $-1.89M | $82000.00 | $-95000.00 | $521000.00 | $-12.95M | $-17.70M | $-17.07M | $-21.69M | $-12.36M | $4.80M | $-6.86M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -10410.6% | -10040.3% | -1471.5% | -58.2% | 10.1% | -15.1% |
| EBIT | $-20.33M | $-14.38M | $-14.05M | $-3.22M | $-7.86M | $4.51M | $-5.20M | $1.79M | $-2.18M | $-662000.00 | $-2.79M | $-7.05M | $-9.89M | $-13.01M | $-18.10M | $-17.35M | $-22.74M | $-12.65M | $4.00M | — |
| Interest expense | $3000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $9000.00 | $126000.00 | $978000.00 | $3.39M | $4.07M | $2.18M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-19.10M | $-13.36M | $-13.60M | $-3.01M | $-7.82M | $4.68M | $-5.16M | $1.84M | $-2.18M | $-659000.00 | $-2.79M | $-7.05M | $-9.89M | $-12.46M | $-18.11M | $-17.19M | $-22.77M | $-16.05M | $-436000.00 | $-10.27M |
| Net income growth (YoY) | — | +30.1% | -1.8% | +77.9% | -159.7% | +159.9% | -210.2% | +135.7% | -217.9% | +69.7% | -323.2% | -152.6% | -40.3% | -26.0% | -45.3% | +5.1% | -32.5% | +29.5% | +97.3% | -2256.6% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -10652.4% | -10113.7% | -1544.9% | -75.5% | -0.9% | -22.6% |